Jennifer Couzin. Show Affiliations »
Abstract
Mesh: See more » AnimalsAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/therapeutic useAutoimmune Diseases/drug therapyCD40 Ligand/immunologyClinical Trials as TopicDrug IndustryGraft Rejection/prevention & controlHumansMultiple Sclerosis/drug therapyPatents as Topic
Substances: See more » Antibodies, MonoclonalCD40 Ligand
Year: 2005 PMID: 15774740 DOI: 10.1126/science.307.5716.1712
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728